China's Wuxi Biologics Working on Programs for Covid-19 Virus: CEO

Apr.12 — Chris Chen, chief executive officer of (Cayman) Inc., a pharmaceutical company developing and manufacturing antibody drugs, discusses how the coronavirus outbreak has been affecting his business, and the company’s related toย the Covid-19 . He speaks with Haslinda Amin and Rishaad Salamat on “Bloomberg Markets: Asia.”